La epidemia de la depresión: cuando la ciencia no se revisa a sí misma

Resumen

La depresión es una epidemia silenciosa y los Millennials y la Generación Z son generaciones deprimidas. Tras estas afirmaciones realizadas en medios de comunicación se encuentra la idea de que la depresión es una epidemia. Esta percepción ha generado tanto un rechazo social como una crítica académica a la psiquiatría. Sin embargo, argumentaré que la depresión no es una epidemia y que la siguiente hipótesis explica el fenómeno actual: las implicaciones prácticas de los problemas epistémicos presentes desde la medicalización de la depresión no han sido revisados. Para ello me apoyo en artículos epidemiológicos sobre la epidemia de depresión y la percepción del aumento de casos de depresión. Estos estudios impiden afirmar la condición epidémica de la depresión y buscan hipótesis explicativas alternativas. Estas hipótesis están relacionadas con los problemas epistémicos de la psiquiatría. Dicha relación se conformó a través de valores no epistémicos en el proceso de medicalización de la depresión. Los problemas epistémicos que implicaban los valores no epistémicos no se han corregido. Esta revisión permite proponer que el proceso de medicalización de la depresión comparte características con un proceso de farmaceuticalización y disease mongering. Estos procesos de medicalización se caracterizan por la falta de rigor epistémico.
  • Referencias
  • Cómo citar
  • Del mismo autor
  • Métricas

Abraham, J. (2008). Sociology of pharmaceuticals development and regulation: a realist empirical research programme. Sociology of Health & Illness, 30(6), 869-885. https://doi.org/10.1111/j.1467-9566.2008.01101.x

Abraham, J. (2010). Pharmaceuticalization of society in context: Theoretical, empirical and health dimensions. Sociology, 44(4), 603-622. https://doi.org/10.1177/0038038510369368

Acelay, C. (2018). Depresión, la pandemia femenina. El mundo. 1 de abril. http://www.elmundo.com

Albalat Peraita, B. (2022). Milenial y generación Z: ¿Por qué son la generación deprimida? The Conversation. 1 de abril. http://www.theconversation.com

Albarracin, D., Ducousso-Lacaze, A., Cohen, D., Gonon, F., Keller, P. y Minard, M. (2015). There is no cure for existence: on the medicalization of psychological distress. Ethical Human Psychology and Psychiatry, 17, 149-158. https://doi.org/10.1891/1559-4343.17.3.149

Andersen, L. M. (2017). Mechanism and reduction in psychiatry. En M. Massimi, J-W. Romejn y G. Schurz (Eds.), EPSA15 Selected Papers: The 5th conference of the European Philosophy of Science Association in Düsseldorf (pp. 111-124). Amsterdam: Springer.

Andrews, P. W., Thomson, J. A., Amstadter, A., Neale, M. C., (2012). Primum non nocere: an evolutionary analysis of whether antidepressants do more harm than good. Frontiers Psychology, 24(3). https://doi.org/10.3389/fpsyg.2012.00117

Avery, R. J., Eisenberg, M. D., Simon, K. I. (2012). The impact of direct-to-consumer televisión and magazine advertising on antidepressant use. Journal of Health Economics, 31(5), 705-718. https://doi.org/10.1016/j.jhealeco.2012.05.002.

Ballesteros, S. (2017). La depresión, epidemia del siglo XIX. Ser. 7 de abril. http://www.cadenaser.com

Baxter, A., Scott, K., Ferrari, A., Norman, R., Vos, T., Whiteford, H. (2014). Challenging the myth of an “epidemic” of common mental disorders: Trends in the global prevalence of anxiety and depression between 1990 and 2010. Depression and Anxiety, 31(6), 1-11. https://doi.org/10.1002/da.22230

Casarotto PC, G. M. (2021). Antidepressant drugs act by directly binding to TRKB neurotrophin receptors. Cell, 184(5), 1299-1313. https://doi.org/10.1016/j.cell.2021.01.034

Caspi, A., Houts, R., Ambler, A., Danese, A., Elliott, M. L., Hariri, A., Harrington, H., Hogan, S., Poulton, R., Ramrakha, S., Rasmussen, L. J. H., Reuben, A., Richmond-Rakerd, L., Sugden, K., Wertz, J., Williams, B. S. y Moffitt, T. E. (2020). Longitudinal Assessment of Mental Health Disorders and Comorbidities Across 4 Decades Among Participants in the Dunedin Birth Cohort Study. JAMA Network Open, 3(4), 203-221. https://doi.org/10.1001/jamanetworkopen.2020.3221

Castells, M. (2009). Comunicación y poder. Madrid: Alianza.

Charland, L. C. (2013). Why psychiatry should fear medicalization. En K. W. Fulford, M. Davies, R. G. Gipps, G. Graham, J. Z. Sadler, G. Stanghellini, et al., (Eds.), The oxford handbook of philosophy and psychiatry: International perspectives in philosophy and psychiatry (pp. 159-175). Oxford: Oxford University Press.

Cipriani, A., Furukawa, T. A., Salanti, G., Chaimani, A., Atkinson, L. Z., Orawa, Y., Leucht, S., Ruhe, H. G., Turner, E. H., Higgins, J., Egger, M., Takeshima, N., Hayasaka, Y., Imai, H., Shinohara, K., Tajika, A., Ioannidis, J. P., Geddes, J. R. (2018). Comparative efficacy of acceptability of 21 antidepressants drugs for the acute treatment of adults with major depressive disorder: a systematic review and netwotk meta-analysis. Lancet, 391(10128), 1357-1366. https://doi.org/10.1016/S0140-6736(17)32802-7

Clarke, A. E., Mamo, L., Fosket, J. R., Fishman, J. R., Shim, J. K. (2010). Biomedicalization: Technoscience, health, and illness in the U.S. Duke University Press.

Cohen, D. y Jacobs, D. H. (2007). Randomized controlled trials of antidepressants: clinically and scientifically irrelevant. Debates in Neuroscience, 1, 44-54. https://doi.org/10.1007/s11559-007-9002-x

Compton, W. M., Conway, K. P., Stinson, F. S., Grant, B. F. (2006). Changes in the prevalence of major depression and comorbid substance use disorders in the United States between 1991-1992 and 2001-2002. American Journal of Psychiatry, 163(12), 2141-2147. https://doi.org/10.1176/ajp.2006.163.12.2141

Conrad, P. (2007). The medicalization of society: On the transformation of human condition into treatable disorders. Baltimore: The John Hopkins University Press.

Cosci, F., Chouinard, G. (2019). The monoamine hypothesis of depression revisited: could it mechanistically novel antidepressant strategies? En J. Quevedo, A. Carvalho y C. A. Zarate (Eds.), Neurobiology of Depression: Road to novel Therapeutics. Amsterdam: Elsevier.

Cristea, I. A., Cuijpers, P. (2015). What if placebo effect explained all the activity of depression treatments? World Psychiatry, 14(3), 310-311. https://doi.org/10.1002/wps.20249

Davies, J., Read, J. (2019). A systematic review into the incidence, severity and duration of antidepressants withdrawal effects: are guidelines evidence-base? Addictive Behaviors, 97, 111-121. https://doi.org/10.1016/j.addbeh.2018.08.027

De Celis Sierra, M. (2018). El ultimo metaanálisis sobre antidepresivos: nada nuevos bajo el sol. Clínica contemporánea, 1(9), 1-5. https://doi.org/10.5093/cc2018a7

De Vries, Y. A., Roest, A. M., de Jonge, P., Cuijpers, P., R., M. M., Bastaasen, J. A. (2017). The cumulative effect of reporting and citation biases on the apparent efficacy of treatments: The case of depression. Psychological Medicine, 48(15), 2453-2455. https://doi.org/10.1017/S0033291718001873

Foucault, M. (1971). Madness and Civilisation. Londres: Travistock.

Frances, A. (2014). ¿Somos todos enfermos mentales?: Manifiesto contra los abusos de la psiquiatría. Barcelona: Editorial Ariel.

Gahemi, N. (2010). The rise and fall of the biopsychosocial model: Reconciling art and science in psychiatry. Baltimore: John Hopkins University Press.

González-Moreno, M., Saborido, C., Teira, D. (2015). Disease-mongering through clinical trials. Studies in History and Philosophy of Biological and Biomedical Sciences, 51, 11-18. https://doi.org/10.1016/j.shpsc.2015.02.007

Grajales, M. (2021). Depresión y ansiedad: La epidemia silenciosa que aceleró el Covid-19. Forbes. 23 de diciembre. http://www.forbes.com

Greenslit, N. P., Kaptchuk, T. J. (2012). Antidepressants and advertising: psychopharmaceuticals in crisis. Yale Journal of Biomedicine, 85(1), 153-158.

Grow, J. M., Park, J. S. y Ham, X. (2006). “Your life is waiting!” Symbolic meanings in direct-to-consumer antidepressants advertising. Journal of Communication Inquiry, 30(2), 163-188. https://doi.org/10.1177/0196859905285315

Harrington, A. (2019). Mind fixed: psychiatry’s troubled research for the biology of mental illness. Nueva York: W. W. Northon & Company.

Healy, D. (2004a). The Creation of Psychopharmacology. Cambridge: Harvard University Press.

Healy, D. (2004b). Shaping the intimate: Influences on the experience of everyday nerves. Social Studies of Science, 34(2), 219-245. https://doi.org/10.1177/0306312704042620

Hidaka, B. (2012). Depression as a disease of modernity: Explanations for increasing prevalence. Journal of Affective Disorders, 140(3), 205-214. https://doi.org/10.1016/j.jad.2011.12.036

Horwitz, A., Wakefield, J. (2007). The loss of sadness: How psychiatry transformed normal sorrow into depressive disorder. Nueva York: Oxford University Press.

Horwitz, A. (2010). How and age of anxiety became an age of depression. The Milkank Quarterly, 88(1), 112-138. https://doi.org/10.1111/j.1468-0009.2010.00591.x

Illich, I. (1975). Nemesis médica: la expropiación de la salud. Barral Editores.

Infosalus (2022). La OMS alerta de que la prevalencia mundial de ansiedad y depresión aumentó en un 25 % en el primer año de la pandemia. Infosalus. 2 de marzo. http://www.infosalus.com

Insel, T., Cuthbert, B., Garvey, M., Heinssen, R., Pine, D. S., Quinn, K., Sanislow, C., Wang, P. (2010). Research domain criteria (RDoC): toward a new classification framework for research on mental disorders. American Journal of Psychiatry, 167(7), 748-751. https://doi.org/10.1176/appi.ajp.2010.09091379

Ioannidis, J. (2008). Effectiveness of antidepressants: an evidence myth constructed from a thousand randomized trials? Philosophy, Ethics, and Humanities in Medicine, 3(14). https://doi.org/10.1186/1747-5341-3-14

Ioannidis, J. (2012). Why science is not necessarily self-correcting. Perspectives on Psychological Science, 7(6), 645-654.

Jeong, A. (2021). Gen Z most stressed by coronavirys, citing pandemic toll on careers, education and relationships, poll says. The Washington Post. 7 de diciembre. http://www.washingtonpost.com

Kaczmarek, E. (2019). How to distinguish medicalization from over-medicalization? Medicine, Health Care and Philosophy, 22, 119-228. https://doi.org/10.1007/s11019-018-9850-1

Kendler, K. (2008). Explanatory models for psychiatric illness. American Journal of Psychiatry, 165(6), 695-702. https://doi.org/10.1176/appi.ajp.2008.07071061

Kessler, R., Chiu, W. T., Delmer, O., Merikangas, K., Walters, E. (2005). Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry, 62(6), 617-627. https://doi.org/10.1001/archpsyc.62.6.617

Kirsch, I., Deacon, B. J., Huedo-Medina, T. B., Scoboria, A., Moore, T. J., Jhonson, B. T. (2008). Initial severity and antidepressant Benefits: a meta-analysis of data submitted to the Food and Drug Administration. PLoS Medicine, 5(2), e45. https://doi.org/10.1371/journal.pmed.0050045

Kirsch, I. (2010). The emperor’s new drugs: Exploding the antidepressant myth. Nueva York: Basic Books.

Kirsch, I. (2014). Antidepressants and the placebo effect. Zeitschrift fur Psychologie, 222(3), 128-134. https://doi.org/10.1027/2151-2604/a000176

Kluth, A. (2020). An epidemic of depression and anxiety among young adults. Bloomber. 22 de agosto. http://bloomberg.com

Koves, V., Brugha, T., Carta, M. G., Lehtinen, V., Agermeyer, M. C., Bernal, M., Xavier, M., Kittel, F., Fryers, T., Aongusa, B. N., Poulsen, H. D., Pull, C., Abad, J. M. H., Katschnig, H., Madianos, M. G., Dalgard, O. S., Bijl, R., Rutz, W., Henderson, J. H., McColl, K. (2004). The state of mental health in the European Union. European Comission. https://ec.europa.eu

La Sexta (2021). Cientos de personas se manifiestan en Madrid para clamar al Gobierno un plan de prevención del suicidio. La Sexta. 11 de septiembre. http://www.lasexta.com.

Liu, B. L. (2017). From serotonin to neuroplasticity: evolvement of theories from major depressive disorder. Frontiers in Cellular Neuroscience, 11(305). https://doi.org/10.3389/fncel.2017.00305

Liu, Q., He, H., Yang, J., Feng, X., Zhao, F., Lyu, J. (2020). Changes in the global burden of depression from 1990 to 2017: Findings from the Global Burden of Disease study. Journal of Psychiatric Research, 126, 134-140. https://doi.org/10.1016/j.jpsychires.2019.08.002

McHenry, L. (2005). Ethical issues in psychopharmacology. Law, Ethics and Medicine, 32, 405-410. https://doi.org/10.1136/jme.2005.013185

Millhouse, T., Porter, J. (2015). A brief history of the development of antidepressant drugs: from monoamines to glutamate. Experimental and Clinical Psychopharmacology, 23(1), 1-21. https://doi.org/10.1037/a0038550

Moncrieff, J., Kirsch, I. (2005). Efficacy of antidepressants in adults. British Medical Journal, 331(7509), 155-157. https://doi.org/10.1136/bmj.331.7509.155

Moncrieff, J. (2008). The creation of the concept of an antidepressant: An historical analysis. Social Science & Medicine, 66(11), 2346-2355. https://doi.org/10.1016/j.socscimed.2008.01.047

Mouzo, J. (2021). La epidemia que subyace tras la covid: los casos de depresión y ansiedad crecen más de un 25 % en el mundo. El País. 9 de octubre. http://www.elpais.com

Moyniham, R. (2012). Disease-mongering. The Politics of Medicine (e-Encyclopedia). https://haiweb.org/encyclopaedia/disease-mongering/

Moynihan, R., Heath, I., Henry, D. (2002). Selling sickness: The pharmaceutical industry and disease monguering. British Medical Journal, 324, 886-891. https://doi.org/10.1136/bmj.324.7342.886

Mulder, R. (2008). An epidemic of depression or the medicalization of distress?. Perspectives in Biological Medicine, 51(2), 238-250. https://doi.org/10.1353/pbm.0.0009

Parens, E. (2011). On good and bad forms of medicalization. Bioethics, 27, 28-35. https://doi.org/10.1111/j.1467-8519.2011.01885.x

Parker, G. (2007). Is depression overdiagnosed? Yes. British Journal of Medicine, 335(7615), 328-329. https://doi.org/10.1353/pbm.0.0009

Parnas, J. (2014). The RDoC program: psychiatry without psyche? World Psychiatry, 13(1), 46-47. https://doi.org/10.1002/wps.20101

Procopio, M. (2008). The multiple outcomes bias in antidepressants research. Medical Hypotheses, 65(2), 395-399. https://doi.org/10.1016/j.mehy.2005.02.037

Read, J., Williams, J. (2018). Adverse effects of antidepressants reported by a large international cohort: emotional blunting, suicidality, and withdrawal effects. Current Drug Safety, 13(3), 176-186. https://doi.org/10.2174/1574886313666180605095130

Rose, N. (2006). Disorders without borders? The expanding scope of psychiatric practice. BioSocieties, 1(4), 465-484. https://doi.org/10.1017/S1745855206004078

Ross, M. (2015). The truth behind U of T’s anti-psychiatry scholarship. Hiffpost. 17 de octubre. http://huffpost.com

Roura, N. (2022). El cerebro millennial: Una aproximación neurocientífica a lo que nos pasa. Buenos Aires: Random Comics.

Schraer, R. (2020). Depression doubles during coronavirus pandemic. BBC News. 18 de agosto. http://bbc.com

Sholl, J. (2017). The muddle of medicalization: patologizing or medicalizing? Theory of Medicine and Bioethics, 38, 265-278. https://doi.org/10.1007/s11017-017-9414-z

Shorter, E. (1998). A History of Psychiatry: From the Era of the Asylum to the Age of Prozac. Hoboken: John Wiley & Sons.

Shorter, E. (2008). Before prozac: The troubled history of mood disorders in psychiatry. Nueva York: Oxford University Press.

Stegenga, J. (2018). Medical Nihilism. Oxford: Oxford University Press.

Strawbridge, R., Young, A., Cleare, A. J. (2017). Biomarkers for depression: recent insights, current challenges and future prospects. Neuropsychiatric Disease and Treatment, 13, 1245-1262. https://doi.org/10.2147/NDT.S114542

Stucchi-Portocarrero, S. (2017). ¿Realmente existe una “epidemia de depresión”? Revista de Neuropsiquiatría, 80(4), 261-264. https://doi.org/10.20453/rnp.v80i4.3240

Tolosa, L. (2021). “¡Vete al médico!”: el grito de un diputado del PP a Errejón en el congreso mientras hablaba de los problemas de salud mental. El País. 17 de marzo. http://www.elpais.com

Twenge, J. (2019). The mental health crisis among America’s youth is real – and staggering. The Conversation, 14 de marzo. http://theconversation.com

Vidal, F., Ortega, F. (2021). ¿Somos nuestro cerebro?: La construcción del sujeto cerebral. Madrid: Alianza.

Vigo, D., Thronicroft, G., Atun, R. (2016). Estimating the true global burden of mental illness. Lancet Psyachiatry, 3(2), 171-178. https://doi.org/10.1016/S2215-0366(15)00505-2

Wakefield, J. (2015). DSM-5, psychiatric epidemiology and the false positives problem. Epidemiology of Psychiatric Science, 24(3), 188-196. https://doi.org/10.1017/S2045796015000116

Wakefield, J., Demazeux, S. (2016) Sadness or Depression?: International perspectives on the depression epidemic and its meaning. Amsterdam: Springer.

Wang, S-M., Han, C., Lee, S-J., J. T-Y., Patkar, A. A., Masand, P. S., Pae, C-U. (2018). Efficacy of antidepressants: bias in randomized clinical trials and related issues. Expert Review in Clinical Pharmacology, 11(1), 15-25. https://doi.org/10.1080/17512433.2017.1377070

Williams, R. D. (2018). Melancholy and the infinite treatments: An investigative study into the marketing of antidepressants (Tesis Doctoral). Universidad de Cardiff.

Williams, S. J., Martin, P., Gabe, J. (2011). The pharmaceuticalisation of society? A framework for analysis. Sociology of Health & Illness, 33(5), 710-725. https://doi.org/10.1111/j.1467-9566.2011.01320.x

Withaker, R. (2018). Anatomía de una epidemia. Madrid: Capitan Swing.

Withley, R. (2012). The antipsychiatric movement: Dead, diminishing or developing? Psychiatric Services, 63(10), 1039-1041. https://doi.org/10.1176/appi.ps.201100484

Zetterqvist, A. V., Mulinari, S. (2013). Misleading advertising for antidepressants in Sweden failure of pharmaceutical industry self-regulation. POS ONE, 8(5), 1-12. https://doi.org/10.1371/journal.pone.0062609

Monterde Fuertes, A. (2022). La epidemia de la depresión: cuando la ciencia no se revisa a sí misma. ArtefaCToS. Revista De Estudios Sobre La Ciencia Y La tecnología, 11(2), 5–28. https://doi.org/10.14201/art2022112528

Descargas

Los datos de descargas todavía no están disponibles.
+